hexobendine has been researched along with papaverine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Kostopoulos, GK; Phillis, JW | 1 |
Pöch, G; Umfahrer, W | 1 |
Herrschaft, H | 1 |
Heiss, WD | 1 |
Cook, P; James, I | 1 |
3 review(s) available for hexobendine and papaverine
Article | Year |
---|---|
[Therapy of inadequate cerebral circulation].
Topics: Actihaemyl; Anticoagulants; Bencyclane; Brain Edema; Cerebrovascular Circulation; Cerebrovascular Disorders; Dexamethasone; Dextrans; Ergot Alkaloids; Hexobendine; Humans; Ischemic Attack, Transient; Meclofenoxate; Nicotinyl Alcohol; Papaverine; Pyrithioxin; Theophylline; Xanthinol Niacinate; Yohimbine | 1976 |
[Pharmacologic modification of the circulation in the brain].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Cardiac Glycosides; Central Nervous System Agents; Cerebrovascular Circulation; Cerebrovascular Disorders; Hemodilution; Hexobendine; Humans; Papaverine; Sympathomimetics; Tomography, Emission-Computed; Vincamine; Xanthines | 1980 |
Drug therapy: cerebral vasodilators (first of two parts).
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cyclandelate; Dementia; Hexobendine; Humans; Nafronyl; Papaverine; Vasodilator Agents | 1981 |
1 trial(s) available for hexobendine and papaverine
Article | Year |
---|---|
Drug therapy: cerebral vasodilators (first of two parts).
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cyclandelate; Dementia; Hexobendine; Humans; Nafronyl; Papaverine; Vasodilator Agents | 1981 |
3 other study(ies) available for hexobendine and papaverine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Adenosine as a putative transmitter in the cerebral cortex. Studies with potentiators and antagonists.
Topics: Action Potentials; Adenine Nucleotides; Adenosine; Animals; Blood Pressure; Caffeine; Cerebral Cortex; Dose-Response Relationship, Drug; Hexobendine; Male; Neurotransmitter Agents; Papaverine; Rats; Receptors, Drug; Structure-Activity Relationship; Theophylline | 1975 |
Differentiation of intestinal smooth muscle relaxation caused by drugs that inhibit phosphodiesterase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminophylline; Ammonium Chloride; Animals; Calcium; Carbachol; Colon; Guinea Pigs; Hexobendine; Isoquinolines; Metaproterenol; Muscle Contraction; Muscle, Smooth; Papaverine; Parasympatholytics; Phosphodiesterase Inhibitors; Verapamil | 1976 |